BARONE, EUGENIO
BARONE, EUGENIO
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
A bioengineering strategy to control ADAM10 activity in living cells
2023 Pastore, Francesco; Battistoni, Martina; Sollazzo, Raimondo; Renna, Pietro; Paciello, Fabiola; Li Puma, Domenica Donatella; Barone, Eugenio; Dagliyan, Onur; Ripoli, Cristian; Grassi, Claudio
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles
2022 Perluigi, M.; Picca, A.; Montanari, E.; Calvani, R.; Marini, F.; Matassa, R.; Tramutola, A.; Villani, A.; Familiari, G.; Domenico, F. D.; Butterfield, D. A.; Oh, K. J.; Marzetti, E.; Valentini, D.; Barone, E.
Aberrant protein networks in Alzheimer disease
2022 Perluigi, M.; Barone, E.
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
2016 Perluigi, Marzia; Barone, Eugenio; DI DOMENICO, Fabio; Butterfield, D. A.
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype
2016 Tramutola, Antonella; Pupo, Gilda; DI DOMENICO, Fabio; Barone, Eugenio; Arena, Andrea; Lanzillotta, Chiara; Broekaart, Diede; Blarzino, Carla; Head, Elizabeth; Butterfield, D. Allan; Perluigi, Marzia
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome
2024 Giallongo, S.; Ferrigno, J.; Caltabiano, R.; Broggi, G.; Alanazi, A. M.; Distefano, A.; Tropea, E.; Tramutola, A.; Perluigi, M.; Volti, G. L.; Barone, E.; Barbagallo, I. A.
Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer’s Disease
2024 Staurenghi, E.; Testa, G.; Leoni, V.; Cecci, R.; Floro, L.; Giannelli, S.; Barone, E.; Perluigi, M.; Leonarduzzi, G.; Sottero, B.; Gamba, P.
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
2012 Cenini, G.; Dowling, A. L. S.; Beckett, T. L.; Barone, E.; Mancuso, C.; Murphy, M. P.; Levine, H.; Lott, I. T.; Schmitt, F. A.; Butterfield, D. A.; Head, E.
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain
2012 D., Butterfield; Barone, Eugenio; DI DOMENICO, Fabio; G., Cenini; R., Sultana; M., Murphy; C., Mancuso; E., Head
Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease
2015 Di Domenico, Fabio; Pupo, Gilda; Mancuso, C; Barone, Eugenio; Paolini, F; Arena, Andrea; Blarzino, Carla; Schmitt, Fa; Head, E; Butterfield, Da; Perluigi, Marzia
Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53
2015 Barone, Eugenio; Cenini, Giovanna; DI DOMENICO, Fabio; Noel, Teresa; Wang, Chi; Perluigi, Marzia; Daret K., S. t. Clair; Butterfield, D. Allan
Behavioural and neuropathological effects of intranasal insulin treatment in a triple-transgenic mouse model of Alzheimer's disease (3xTg-AD)
2017 Calcagnini, Silvio; Barone, Eugenio; Lavecchia, ANGELO MICHELE; Lancioni, Martina; Meconi, Annachiara; Perluigi, Marzia; Cassano, Tommaso
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling
2022 Vasavda, Chirag; Semenza, Evan R; Liew, Jason; Kothari, Ruchita; Dhindsa, Ryan S; Shanmukha, Shruthi; Lin, Anthony; Tokhunts, Robert; Ricco, Cristina; Snowman, Adele M; Albacarys, Lauren; Pastore, Francesco; Ripoli, Cristian; Grassi, Claudio; Barone, Eugenio; Kornberg, Michael D; Dong, Xinzhong; Paul, Bindu D; Snyder, Solomon H
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment
2011 Barone, Eugenio; DI DOMENICO, Fabio; Cenini, G; Sultana, R; Cini, Chiara; Preziosi, P; Perluigi, Marzia; Mancuso, C; Butterfield, Da
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.
2013 DI DOMENICO, Fabio; Perluigi, Marzia; Barone, Eugenio
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease
2018 Triani, F; Tramutola, A; Di Domenico, F; Sharma, N; Butterfield, Da; Head, E; Perluigi, M; Barone, E
Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β
2024 Lanzillotta, Chiara; Tramutola, Antonella; Lanzillotta, Simona; Greco, Viviana; Pagnotta, Sara; Sanchini, Caterina; Di Angelantonio, Silvia; Forte, Elena; Rinaldo, Serena; Paone, Alessio; Cutruzzolà, Francesca; Cimini, Flavia Agata; Barchetta, Ilaria; Cavallo, Maria Gisella; Urbani, Andrea; Butterfield, D Allan; Di Domenico, Fabio; Paul, Bindu D; Perluigi, Marzia; Duarte, Joao M N; Barone, Eugenio
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease
2019 Barone, E; Tramutola, A; Triani, F; Calcagnini, S; Di Domenico, F; Ripoli, C; Gaetani, S; Grassi, C; Butterfield, Da; Cassano, T; Perluigi, M
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control
2021 Cimini, F. A.; Barchetta, I.; Zuliani, I.; Pagnotta, S.; Bertoccini, L.; Dule, S.; Zampieri, M.; Reale, A.; Baroni, M. G.; Cavallo, M. G.; Barone, E.
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease
2012 Barone, Eugenio; C., Mancuso; DI DOMENICO, Fabio; R., Sultana; M. P., Murphy; E., Head; D. A., Butterfield
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A bioengineering strategy to control ADAM10 activity in living cells | 2023 | Pastore, Francesco; Battistoni, Martina; Sollazzo, Raimondo; Renna, Pietro; Paciello, Fabiola; Li Puma, Domenica Donatella; Barone, Eugenio; Dagliyan, Onur; Ripoli, Cristian; Grassi, Claudio | |
| Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles | 2022 | Perluigi, M.; Picca, A.; Montanari, E.; Calvani, R.; Marini, F.; Matassa, R.; Tramutola, A.; Villani, A.; Familiari, G.; Domenico, F. D.; Butterfield, D. A.; Oh, K. J.; Marzetti, E.; Valentini, D.; Barone, E. | |
| Aberrant protein networks in Alzheimer disease | 2022 | Perluigi, M.; Barone, E. | |
| Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways | 2016 | Perluigi, Marzia; Barone, Eugenio; DI DOMENICO, Fabio; Butterfield, D. A. | |
| Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype | 2016 | Tramutola, Antonella; Pupo, Gilda; DI DOMENICO, Fabio; Barone, Eugenio; Arena, Andrea; Lanzillotta, Chiara; Broekaart, Diede; Blarzino, Carla; Head, Elizabeth; Butterfield, D. Allan; Perluigi, Marzia | |
| Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome | 2024 | Giallongo, S.; Ferrigno, J.; Caltabiano, R.; Broggi, G.; Alanazi, A. M.; Distefano, A.; Tropea, E.; Tramutola, A.; Perluigi, M.; Volti, G. L.; Barone, E.; Barbagallo, I. A. | |
| Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer’s Disease | 2024 | Staurenghi, E.; Testa, G.; Leoni, V.; Cecci, R.; Floro, L.; Giannelli, S.; Barone, E.; Perluigi, M.; Leonarduzzi, G.; Sottero, B.; Gamba, P. | |
| Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome | 2012 | Cenini, G.; Dowling, A. L. S.; Beckett, T. L.; Barone, E.; Mancuso, C.; Murphy, M. P.; Levine, H.; Lott, I. T.; Schmitt, F. A.; Butterfield, D. A.; Head, E. | |
| Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain | 2012 | D., Butterfield; Barone, Eugenio; DI DOMENICO, Fabio; G., Cenini; R., Sultana; M., Murphy; C., Mancuso; E., Head | |
| Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease | 2015 | Di Domenico, Fabio; Pupo, Gilda; Mancuso, C; Barone, Eugenio; Paolini, F; Arena, Andrea; Blarzino, Carla; Schmitt, Fa; Head, E; Butterfield, Da; Perluigi, Marzia | |
| Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53 | 2015 | Barone, Eugenio; Cenini, Giovanna; DI DOMENICO, Fabio; Noel, Teresa; Wang, Chi; Perluigi, Marzia; Daret K., S. t. Clair; Butterfield, D. Allan | |
| Behavioural and neuropathological effects of intranasal insulin treatment in a triple-transgenic mouse model of Alzheimer's disease (3xTg-AD) | 2017 | Calcagnini, Silvio; Barone, Eugenio; Lavecchia, ANGELO MICHELE; Lancioni, Martina; Meconi, Annachiara; Perluigi, Marzia; Cassano, Tommaso | |
| Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling | 2022 | Vasavda, Chirag; Semenza, Evan R; Liew, Jason; Kothari, Ruchita; Dhindsa, Ryan S; Shanmukha, Shruthi; Lin, Anthony; Tokhunts, Robert; Ricco, Cristina; Snowman, Adele M; Albacarys, Lauren; Pastore, Francesco; Ripoli, Cristian; Grassi, Claudio; Barone, Eugenio; Kornberg, Michael D; Dong, Xinzhong; Paul, Bindu D; Snyder, Solomon H | |
| Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment | 2011 | Barone, Eugenio; DI DOMENICO, Fabio; Cenini, G; Sultana, R; Cini, Chiara; Preziosi, P; Perluigi, Marzia; Mancuso, C; Butterfield, Da | |
| Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain. | 2013 | DI DOMENICO, Fabio; Perluigi, Marzia; Barone, Eugenio | |
| Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease | 2018 | Triani, F; Tramutola, A; Di Domenico, F; Sharma, N; Butterfield, Da; Head, E; Perluigi, M; Barone, E | |
| Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β | 2024 | Lanzillotta, Chiara; Tramutola, Antonella; Lanzillotta, Simona; Greco, Viviana; Pagnotta, Sara; Sanchini, Caterina; Di Angelantonio, Silvia; Forte, Elena; Rinaldo, Serena; Paone, Alessio; Cutruzzolà, Francesca; Cimini, Flavia Agata; Barchetta, Ilaria; Cavallo, Maria Gisella; Urbani, Andrea; Butterfield, D Allan; Di Domenico, Fabio; Paul, Bindu D; Perluigi, Marzia; Duarte, Joao M N; Barone, Eugenio | |
| Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease | 2019 | Barone, E; Tramutola, A; Triani, F; Calcagnini, S; Di Domenico, F; Ripoli, C; Gaetani, S; Grassi, C; Butterfield, Da; Cassano, T; Perluigi, M | |
| Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control | 2021 | Cimini, F. A.; Barchetta, I.; Zuliani, I.; Pagnotta, S.; Bertoccini, L.; Dule, S.; Zampieri, M.; Reale, A.; Baroni, M. G.; Cavallo, M. G.; Barone, E. | |
| Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease | 2012 | Barone, Eugenio; C., Mancuso; DI DOMENICO, Fabio; R., Sultana; M. P., Murphy; E., Head; D. A., Butterfield |